|

ketamine hydrochloride Clinical Trials

11 actively recruiting trials across 4 locations

Also known as: Ketalar, N01AX03, Racemic ketamine (R, S)-Ketamine

Other7 trials

Glutamate Emotion Memory Study
N/A
Imaging Neural Correlates of Ketamine Using PET/MR
Phase 1
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Phase 3
Ketamine Augmentation of ECT in Treatment-Resistant Depression
Phase 3
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Phase 3
Understanding and Treating Suicidal Ideation With Ketamine
Phase 2/3
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
Phase 2

New Haven, Connecticut1 trial

Imaging Depression in Parkinson's Disease

Yale University

Phase 2

Jacksonville, Florida1 trial

A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients

Mayo Clinic Florida

Phase 2

Bethesda, Maryland1 trial

Neurobiology of Suicide

National Institutes of Health Clinical Center

Phase 2

Ann Arbor, Michigan1 trial

Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

VA Ann Arbor Healthcare System, Ann Arbor, MI

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.